| Primary |
| Kawasaki's Disease |
100.0% |
|
| Drug Ineffective |
50.0% |
| Meningitis Aseptic |
50.0% |
|
| Secondary |
| Product Used For Unknown Indication |
33.6% |
| Drug Use For Unknown Indication |
23.4% |
| Lewis-sumner Syndrome |
5.1% |
| Optic Neuropathy |
4.3% |
| Acute Polyneuropathy |
3.4% |
| Dermatomyositis |
3.4% |
| Off Label Use |
3.0% |
| Meningitis Pneumococcal |
2.8% |
| Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii Stage Iii |
2.6% |
| Hypertension |
2.6% |
| Polyneuropathy |
2.6% |
| Neuropathy Peripheral |
2.3% |
| Demyelinating Polyneuropathy |
1.7% |
| Influenza Like Illness |
1.7% |
| Micturition Disorder |
1.5% |
| Analgesic Therapy |
1.3% |
| Erythema |
1.3% |
| Neuralgia |
1.3% |
| Sedation |
1.3% |
| Pneumococcal Bacteraemia |
1.1% |
|
| Renal Failure Acute |
14.1% |
| Stevens-johnson Syndrome |
10.6% |
| Nail Disorder |
9.4% |
| Psoriasis |
8.2% |
| Pulmonary Embolism |
8.2% |
| Optic Neuropathy |
5.9% |
| Renal Tubular Disorder |
5.9% |
| Hepatitis |
4.7% |
| Toxic Skin Eruption |
4.7% |
| Hypertension |
3.5% |
| Neutropenia |
3.5% |
| Vomiting |
3.5% |
| Hypocapnia |
2.4% |
| Oedema Peripheral |
2.4% |
| Renal Failure |
2.4% |
| Sepsis |
2.4% |
| Shock Haemorrhagic |
2.4% |
| Tonsillitis |
2.4% |
| Visual Field Defect |
2.4% |
| Bronchopulmonary Aspergillosis |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
52.9% |
| Chronic Lymphocytic Leukaemia |
9.5% |
| Lung Transplant |
6.3% |
| Dermatomyositis |
3.7% |
| Urinary Tract Infection |
3.2% |
| Drug Use For Unknown Indication |
2.1% |
| Lung Disorder |
2.1% |
| Aplastic Anaemia |
1.6% |
| Bone Marrow Conditioning Regimen |
1.6% |
| Bone Marrow Transplant |
1.6% |
| Granulomatosis With Polyangiitis |
1.6% |
| Hypertension |
1.6% |
| Immunomodulatory Therapy |
1.6% |
| Pain |
1.6% |
| Pneumonia Herpes Viral |
1.6% |
| Polymyositis |
1.6% |
| Prophylaxis Against Graft Versus Host Disease |
1.6% |
| Pulmonary Arterial Hypertension |
1.6% |
| Unevaluable Event |
1.6% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
1.1% |
|
| Thrombocytopenia |
25.0% |
| Weight Decreased |
10.0% |
| Vomiting |
7.5% |
| Blood Amylase Increased |
5.0% |
| Cytolytic Hepatitis |
5.0% |
| Hemiparesis |
5.0% |
| Hepatocellular Damage |
5.0% |
| Hepatocellular Injury |
5.0% |
| Pyrexia |
5.0% |
| Acute Coronary Syndrome |
2.5% |
| Adenocarcinoma Pancreas |
2.5% |
| Aspartate Aminotransferase Increased |
2.5% |
| Asthma |
2.5% |
| Bronchopulmonary Aspergillosis |
2.5% |
| Cholestasis |
2.5% |
| Colitis Ischaemic |
2.5% |
| Cough |
2.5% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.5% |
| Dyspnoea |
2.5% |
| Eating Disorder |
2.5% |
|
